GDRX - GoodRx Holdings, Inc.
After hours:
Chart Events
Price Crosses Moving Average
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 5.53 |
| Open | 5.51 |
| Bid | 5.18 x 2200 |
| Ask | 5.67 x 1300 |
| Day's Range | 5.28 - 5.57 |
| 52 Week Range | 3.82 - 10.37 |
| Volume | |
| Avg. Volume | 1,514,895 |
| Market Cap | 2.155B |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 |
| Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.49 |
Fair Value
Related Research
Business WireGoodRx to Present at the Jefferies Healthcare Conference
SANTA MONICA, Calif., May 25, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Jefferies Healthcare Conference in New York, NY on Thursday, June 8, 2023 at 12:30 p.m. Pacific Time (3:30 p.m. Eastern Time).
Motley FoolGoodRx (GDRX) Q1 2023 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the GoodRx first quarter 2023 earnings call. Joining me today are Doug Hirsch, our chief mission officer; Trevor Bezdek, our chairman; Karsten Voermann, our chief financial officer; and Scott Wagner, our interim chief executive officer. Before we begin, I would like to remind everyone that this call will contain forward-looking statements.
Yahoo FinanceWhy indie pharmacies, with the help of the likes of Mark Cuban, are on the rise
Independent pharmacies and startups such as Cigna's Express Scripts and Mark Cuban's Cost Plus Drugs are partnering up to address a coverage gap for some Americans.
BenzingaWhat's Going On With GoodRx Stock Today: Q1 Beat, Outlook Revised Downward
GoodRx Holdings Inc (NASDAQ: GDRX) reported Q1 sales of $183.99 million, down 10% Y/Y, beating the consensus of $182.08 million and the management guidance of $181-183 million. Prescription transactions revenue (PTR) decreased 13% to $134.9 million compared to $155.5 million, driven primarily by a 5% decrease in Monthly Active Consumers and an ongoing shift in the volume of prescription transactions to certain retailers with lower pricing principally due to the sustained impact of the grocer iss
ZacksGoodRx Holdings, Inc. (GDRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksGoodRx Holdings, Inc. (GDRX) Tops Q1 Earnings and Revenue Estimates
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 16.67% and 1.16%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireGoodRx Reports First Quarter 2023 Results
SANTA MONICA, Calif., May 10, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), a leading digital healthcare platform, has released its financial results for the first quarter 2023.
Simply Wall St.GoodRx Holdings, Inc. (NASDAQ:GDRX) Might Not Be As Mispriced As It Looks After Plunging 27%
GoodRx Holdings, Inc. ( NASDAQ:GDRX ) shareholders that were waiting for something to happen have been dealt a blow...
Motley FoolWhy Shares of GoodRx Holdings Fell This Week
Shares of GoodRx Holdings (NASDAQ: GDRX) dropped 18.9% this week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock closed at $5.76 last week and fell to as low as $4.49 on Friday on news regarding a shake-up at the company, which offers virtual doctor visits and lets users get discounts on prescription drugs. GoodRx is a digital platform designed to help consumers pay less for prescription drugs.
Business WireGoodRx to Present at the BofA Securities 2023 Health Care Conference
SANTA MONICA, Calif., April 27, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the BofA Securities 2023 Health Care Conference in Las Vegas, NV, on Thursday, May 11, 2023 at 9:20 a.m. Pacific Time (12:20 p.m. Eastern Time).
Business WireGoodRx Expands Executive Team With New Interim CEO
SANTA MONICA, Calif., April 25, 2023--GoodRx Holdings, Inc. (NASDAQ: GDRX), a leading digital healthcare platform, today announced that Scott Wagner has been appointed Interim Chief Executive Officer, effective April 25, 2023. Co-founders Doug Hirsch and Trevor Bezdek have transitioned into new roles as Chief Mission Officer and Chairman, respectively. Wagner will work closely with Hirsch and Bezdek, who remain part of the GoodRx leadership team, to accelerate product innovation, strengthen the
Business WireGoodRx Announces Date for First Quarter 2023 Earnings Release and Conference Call
SANTA MONICA, Calif., April 12, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), a leading digital healthcare platform, today announced it will release its first quarter 2023 financial results before U.S. markets open on Wednesday, May 10, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.
- Simply Wall St.
Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Motley FoolThese 2 Stocks Crashed 85% Last Year But Are off to Hot Starts in 2023
Many growth stocks did even worse in 2022, including Coinbase Global (NASDAQ: COIN) and GoodRx (NASDAQ: GDRX), which each saw their share prices collapse by more than 85% over the course of the year. Coinbase runs a platform for buying and selling cryptocurrencies. Because of that, its stock performance tends to be closely related to the popularity of Bitcoin.
- Simply Wall St.
Is Now The Time To Look At Buying GoodRx Holdings, Inc. (NASDAQ:GDRX)?
GoodRx Holdings, Inc. ( NASDAQ:GDRX ), is not the largest company out there, but it led the NASDAQGS gainers with a...
ZacksTeladoc's (TDOC) BetterHelp Faces FTC Hurdle, to Pay $7.8M
Teladoc's (TDOC) BetterHelp business is expected to continue implementing more comprehensive privacy standards.
Motley Fool8 of the Happiest Companies for Remote Workers
As adults, we understand that no job is rainbows and unicorns every day. A Fast Company-Harris Poll found that 59% of middle-income workers think about changing jobs. Many prefer a hybrid schedule that takes them to the office two or three days a week.
Insider MonkeyGoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2022 Earnings Call Transcript
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2022 Earnings Call Transcript February 28, 2023 Company Representatives: Doug Hirsch – Co-Founders, Co-Chief Executive Officer Trevor Bezdek – Co-Founders, Co-Chief Executive Officer Karsten Voermann – Chief Financial Officer Aubrey Reynolds – Senior Investor Relations Manager Operator: Good day! And welcome to the GoodRx, Fourth Quarter and Full Year 2022 […]
Motley FoolWhy GoodRx Stock Rallied Wednesday Morning
The prescription drug discount and digital health specialist delivered results that weren't as bad as investors had feared.
- Motley Fool
GoodRx (GDRX) Q4 2022 Earnings Call Transcript
Joining me today are Doug Hirsch and Trevor Bezdek, our co-founders and co-chief executive officers; and Karsten Voermann, our chief financial officer. Before we begin, I'd like to remind everyone that this call will contain forward-looking statements.
ZacksGoodRx Holdings, Inc. (GDRX) Q4 Earnings and Revenues Surpass Estimates
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 40% and 3.33%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business WireGoodRx Reports Fourth Quarter and Full Year 2022 Results
SANTA MONICA, Calif., February 28, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, has released its financial results for the fourth quarter and full year 2022.
- Simply Wall St.
Private equity firms own 34% of GoodRx Holdings, Inc. (NASDAQ:GDRX) shares but individual investors control 38% of the company
Key Insights GoodRx Holdings' significant individual investors ownership suggests that the key decisions are influenced...
Business WireGoodRx to Present at the Cowen 43rd Annual Health Care Conference
SANTA MONICA, Calif., February 21, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Cowen 43rd Annual Health Care Conference in Boston, MA on Tuesday, March 7, 2023 at 6:50 a.m. Pacific Time (9:50 a.m. Eastern Time).
Motley Fool2 Healthcare Companies That Could Be Acquired Within 5 Years
Two modestly valued healthcare companies that I can see being bought out within the next five years are Maravai LifeSciences (NASDAQ: MRVI) and GoodRx Holdings (NASDAQ: GDRX). The highly successful mRNA-based COVID-19 vaccines from Moderna and Pfizer put a spotlight on mRNA, and that could open up more opportunities in the future. Last month Moderna released results on its mRNA-based vaccine candidate for the respiratory syncytial virus that showed an incredibly high efficacy rate of 84%.
